Edition:
United Kingdom

Intersect Ent Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

29.78USD
4:12pm BST
Change (% chg)

$0.20 (+0.68%)
Prev Close
$29.58
Open
$29.57
Day's High
$29.93
Day's Low
$29.35
Volume
9,934
Avg. Vol
80,345
52-wk High
$42.90
52-wk Low
$25.15

Chart for

About

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology... (more)

Overall

Beta: --
Market Cap(Mil.): $894.66
Shares Outstanding(Mil.): 29.19
Dividend: --
Yield (%): --

Financials

  XENT.OQ Industry Sector
P/E (TTM): -- 32.37 33.73
EPS (TTM): -0.70 -- --
ROI: -16.93 14.01 14.31
ROE: -17.07 16.77 16.04

BRIEF-Intersect ENT Reports Qtrly Loss Per Share $0.21

* Q1 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S

01 May 2018

Competitors

  Price Chg
Medtronic PLC (MDT.N) $97.08 +0.53

Earnings vs. Estimates